跳转至内容
Merck
所有图片(5)

Key Documents

ABS45

Sigma-Aldrich

抗-磷酸-MYPT1(Thr696)抗体

from rabbit, purified by affinity chromatography

别名:

Myosin phosphatase target subunit 1, Myosin phosphatase-targeting subunit 1, Protein phosphatase myosin-binding subunit, myosin phosphatase, target subunit 1, protein phosphatase 1, regulatory (inhibitor) subunit 12

登录查看公司和协议定价


About This Item

分類程式碼代碼:
12352203
eCl@ss:
32160702
NACRES:
NA.41

生物源

rabbit

品質等級

抗體表格

affinity isolated antibody

抗體產品種類

primary antibodies

無性繁殖

polyclonal

分子量

(~130 kDa observed; 115.28 kDa calculated. Uncharacterized bands may be observed in some lysate(s).)

純化經由

affinity chromatography

物種活性

human

物種活性(以同源性預測)

canine (based on 100% sequence homology), rat (based on 100% sequence homology), primate (based on 100% sequence homology), mouse (based on 100% sequence homology), chicken (based on 100% sequence homology), horse (based on 100% sequence homology), Xenopus (based on 100% sequence homology)

技術

inhibition assay: suitable (Peptide Inhibition Assay)
western blot: suitable

NCBI登錄號

UniProt登錄號

運輸包裝

wet ice

目標翻譯後修改

phosphorylation (pThr696)

基因資訊

human ... PPP1R12A(4659)

一般說明

Anti-phospho-MYPT1 (Thr696,货号ABS45)是一种兔多克隆抗体,可检测苏氨酸696上的MYPT1磷酸化,经测试可用于蛋白质印迹和肽抑制分析。
Purified rabbit polyclonal antibody in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide

特異性

该兔多克隆抗体可特异性检测苏氨酸696上的MYPT1磷酸化。

免疫原

KLH偶联的线性肽,对应于人MYPT的磷酸苏氨酸696周围的11个氨基酸。
表位:磷酸化Thr696

應用

抗-磷酸-MYPT1(Thr696)抗体是一种用于WB的抗磷酸MYPT1(Thr696)的抗体。
研究子类别
激酶 & 磷酸酶
研究类别
信号传导
蛋白质印迹(SNAP ID)分析: 0.1 µg/mL先前批次在10 µg NIH/3T3和细胞裂解物中检测到MYPT1。

品質

通过蛋白质印迹对 HEK293 细胞裂解液进行了评估。
蛋白质印迹分析:使用0.1 µg/mL该抗体检测10 µg Calyculin/Okadaic处理和未处理的HEK293细胞裂解物在Thr696磷酸化的MYPT1。

標靶描述

蛋白磷酸酶1调节亚基12A(UniProt: O14974;也称肌球蛋白磷酸酶靶向亚基1,肌球蛋白磷酸酶靶标亚基1,蛋白磷酸酶肌球蛋白结合亚基,由PPP1R12A(也称MBS、MYPT1)基因(基因ID:4659)编码。 肌球蛋白轻链磷酸酶及其调节亚基,肌球蛋白磷酸酶靶向亚基1(MYPT1),在肌球蛋白轻链激酶的作用下调节肌球蛋白轻链的Ca2+依赖性磷酸化,该激酶是平滑肌收缩所必需的。 肌球蛋白磷酸酶调节在鸟苷三磷酸酶Rho下游肌动蛋白和肌球蛋白的相互作用,其通过Rho激酶的作用抑制肌球蛋白磷酸酶。MYPT1位于应激纤维上,并分布在细胞膜附近和细胞间接触处,以调节肌球蛋白磷酸酶的活性。它是在ROCK1和CDC42BP的共同作用下在Thr-696上磷酸化,Thr-696通过分子内机制抑制PP1C 活性。PPP1R12A 的突变与泌尿生殖和/或脑畸形综合征(GUBS)有关,该综合征是一种常染色体显性综合征,特征是多种先天性异常,包括泌尿生殖系统畸形和脑畸形。已经描述了通过选择性剪接产生的MYPT1的五种亚型。(参考文献:Qiao, J., et al. (2014)。J. Biol. Chem. 289(32):22512-22523)。

聯結

替代品:07-251

外觀

亲和纯化
纯化的兔多克隆抗体,含有0.1 M Tris-甘氨酸(pH 7.4)、150 mM NaCl和0.05%叠氮化钠。

儲存和穩定性

自收到之日起,在 2-8°C 条件下可稳定保存1年

分析報告

对照
Calyculin/Okadaic处理和未处理的HEK293细胞裂解物

其他說明

浓度:请参考批次特异性浓缩物的分析证书。

免責聲明

除非我们的产品目录或产品附带的其他公司文档另有说明,否则我们的产品仅供研究使用,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。

未找到合适的产品?  

试试我们的产品选型工具.

儲存類別代碼

12 - Non Combustible Liquids

水污染物質分類(WGK)

WGK 1

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Rho-kinase inhibition alleviates pulmonary hypertension in transgenic mice expressing a dominant-negative type II bone morphogenetic protein receptor gene.
Yasuda, T; Tada, Y; Tanabe, N; Tatsumi, K; West, J
American Journal of Physiology. Lung Cellular and Molecular Physiology null
Sedef Iskit et al.
Oncotarget, 7(28), 42859-42872 (2016-07-05)
Breast cancer is the second most common cause of cancer-related deaths worldwide among women. Despite several therapeutic options, 15% of breast cancer patients succumb to the disease owing to tumor relapse and acquired therapy resistance. Particularly in triple-negative breast cancer
James R W Conway et al.
Scientific reports, 7(1), 16887-16887 (2017-12-06)
Organotypic co-cultures bridge the gap between standard two-dimensional culture and mouse models. Such assays increase the fidelity of pre-clinical studies, to better inform lead compound development and address the increasing attrition rates of lead compounds within the pharmaceutical industry, which
Mechanisms underlying potentiation of endothelin-1-induced myofilament Ca(2+) sensitization after subarachnoid hemorrhage.
Kikkawa, Y; Matsuo, S; Kameda, K; Hirano, M; Nakamizo, A; Sasaki, T; Hirano, K
Journal of Cerebral Blood Flow and Metabolism null
Verena K Kretzschmann et al.
Arteriosclerosis, thrombosis, and vascular biology, 34(2), 294-303 (2013-11-29)
Pretubulysin (PT) is a novel, synthetically accessible myxobacterial compound that acts as a tubulin-depolymerizing agent and inhibits cancer cell growth in vitro and in vivo. Moreover, PT was found to attenuate tumor angiogenesis. Here, we hypothesized that PT could exert

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门